Literature DB >> 12560278

Thromboembolism associated with the new contraceptive Yasmin.

Kees van Grootheest1, Tom Vrieling.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12560278      PMCID： PMC140765          DOI： 10.1136/bmj.326.7383.257

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  1 in total

1.  Dutch GPs warned against new contraceptive pill.

Authors:  Tony Sheldon
Journal:  BMJ       Date:  2002-04-13
  1 in total
  4 in total

1.  Systemic sclerosis following oral contraception.

Authors:  Lorenzo Beretta; Monica Caronni; Raffaella Scorza
Journal:  Clin Rheumatol       Date:  2004-07-14       Impact factor: 2.980

2.  Deep vein thrombosis and pulmonary embolism reported in the Prescription Event Monitoring Study of Yasmin.

Authors:  Hilary M Pearce; Deborah Layton; Lynda V Wilton; Saad A W Shakir
Journal:  Br J Clin Pharmacol       Date:  2005-07       Impact factor: 4.335

3.  Arterial thrombosis and drospirenone-containing pill (Yasmin). Is the pill to be absolutely avoided by women who smoke?

Authors:  Antonio Girolami; Fabiana Tezza; Emanuele Allemand; Bruno Girolami
Journal:  J Thromb Thrombolysis       Date:  2007-12-23       Impact factor: 2.300

4.  The venous thrombotic risk of oral contraceptives, effects of oestrogen dose and progestogen type: results of the MEGA case-control study.

Authors:  A van Hylckama Vlieg; F M Helmerhorst; J P Vandenbroucke; C J M Doggen; F R Rosendaal
Journal:  BMJ       Date:  2009-08-13
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.